Last reviewed · How we verify
Pseudomonas gastrointestinal tract infection
Approved treatments
- Recarbrio · Merck & Co.
Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pseudomonas gastrointestinal tract infection patent landscape — cliff calendar, originator estates, attackable patents
- Pseudomonas gastrointestinal tract infection treatment landscape brief
- Pseudomonas gastrointestinal tract infection treatment updates RSS
Frequently asked questions about Pseudomonas gastrointestinal tract infection
What drugs treat Pseudomonas gastrointestinal tract infection?
Tracked treatments include Recarbrio.
What is the treatment for Pseudomonas gastrointestinal tract infection?
Standard treatment for Pseudomonas gastrointestinal tract infection includes Recarbrio. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Pseudomonas gastrointestinal tract infection patent cliff · Pseudomonas gastrointestinal tract infection CI report
- Treatment: Recarbrio · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing